Pharmaceutical formulation with nonsteroidal antiphlogistic agents and nucleic acids for the internalization of nucleic acids into eucaryotic cells
Details for Australian Patent Application No. 2003260278 (hide)
International Classifications
Event Publications
20 November 2003 Complete Application Filed
Priority application(s): 102 40 418.6 02.09.02 DE
13 May 2004 Application Open to Public Inspection
Published as AU-B-2003260278
5 June 2008 Application Accepted
Published as AU-B-2003260278
2 October 2008 Standard Patent Sealed
30 October 2008 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 16 Sep 2008. Address for service in Australia - Wrays Ground Floor 56 Ord Street West Perth WA 6005
26 March 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 16 Sep 2008
31 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003260277-Decoy-Oligonucleotide-inhbition of CD40-expression
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser